Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

• Status: Completed
• Trial end date: 2014-01-01

Summary

The purpose of this study was to assess the safety and effectiveness of once daily oral administration of dexlansoprazole delayed-release capsules in adolescent participants with symptomatic non-erosive gastroesophageal reflux disease (GERD).

• Phase: Phase 2

Details

• Lead Sponsor: Takeda
• Treatments: Dexlansoprazole; Lansoprazole